US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted A61KA61K31/343A61K31/352
Quick answer
US patent 12377068 (In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors) held by Provectus Pharmatech, Inc. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/343, A61K31/352, A61K31/365, A61K31/4745